Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-02-17
1989-03-07
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514242, 514250, 514253, 514254, 514256, 514269, 514272, 514274, 514280, 514281, 514252, 514284, 514285, 514286, 514287, 514289, 514292, 514297, 544182, 544230, 544238, 544298, 544316, 544342, 546 15, 546 43, 546 44, 546 62, 546 63, 546 64, 546 65, 546 81, 546 82, 546 83, 546 84, 546 88, 546 74, 546 93, 546103, 546104, A61K 31435, C07D47104, C07D491044, C07D491056
Patent
active
048107085
ABSTRACT:
Novel polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives are disclosed which are useful for treating allergic reactions, inflammation, peptic ulcers, hypertension, and hyperproliferative skin diseases and for suppressing the immune response in mammals. Methods for preparing said compounds are also disclosed.
REFERENCES:
patent: 3931199 (1976-01-01), Nakanishi et al.
patent: 3931205 (1976-01-01), Nakanishi et al.
patent: 4596809 (1986-06-01), Sherlock
Goodman et al The Pharmacological Basis of Therapeutics, 6Ed. p. 28.
Chem. Ab. vol. 96: No. 217821K, p. 743, (1982).
Chem. Ab. vol. 85, No. 108567; p. 455 (1976).
Khim-Farm. Zh. 10(5) pp. 18-22 (1976).
Liebigs Annalen der Chemie (1984) F. Eiden pp. 1759-1777.
Chem. Ab. 70 (1969) No. 77902y-pp. 348-349.
Zh. Obshch. Khim. 38(9)-pp. 2051-2064 (1968).
Fournier et al., Bulletin De La Societe Chimique De France, 1968, No. 1, pp. 364-369.
Derwent Abstract of Japanese published application J5 8144-391A.
Hawkins, et al., Chem. Soc. Perkins Tans. I, 1983, pp. 2077-2087.
Chemical Abstracts, vol. 101, Abstract No. 38382t, 1984.
Bernath, et al., J. Heterocycl. Chem. 16(1), 137-44 (1979).
Chem. Abstracts, 88(13): 89668m (1978) p. 522.
Chem. Abstracts, 85(3): 21376x (1976) p. 695.
Chem. Abstracts, 74(15): 74797q (1971) p. 303.
Chem. Abstracts, 91(5): 32785e (1979) p. 33.
Chem. Abstracts, 88(19): 130847j (1978) p. 32.
Chem. Abstracts, 93(19): 186323f (1980) p. 863.
Chem. Abstracts, 88(3): 22701y (1978) p. 617.
Chem. Abstracts, 87(17): 127017n (1977) p. 28.
Chem. Abstracts, 84(9): 59429j (1976) p. 522.
Chem. Abstracts, 67(9): 43655t (1967) 428-431.
Chem. Abstracts, 85(7): 46621m (1976) p. 536.
Chem. Abstracts, 90(25): 203821z (1979) pp. 600-601.
Chem. Abstracts, 93(5): 46364v (1980) p. 902.
Chem. Abstracts, 95(13): 115339w (1981) p. 686.
Chem. Abstracts, 80(19): 108503g (1974) p. 419.
Chem. Abstracts, 82(1): 4230r (1976) pp. 367-368.
Chem. Abstracts, 97(11): 92173n (1982) p. 761.
Chem. Abstracts, 86(7): 43594q (1977) p. 536.
Chem. Abstracts, 91(15): 123609s (1979) p. 588.
Chem. Abstracts, 98: 215861n (1983) p. 584.
Chem. Abstracts, 69: 67264g (1968) 6280-6281.
Friary Richard J.
Ganguly Ashit K.
Schwerdt John H.
Seidl Vera A.
Siegel Marvin I.
Billups Richard C.
Lee Mary C.
Miller Stephen I.
Nelson James R.
Richter J.
LandOfFree
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1669009